This Moment In Medicine: First-Line HER2+ Metastatic Breast Cancer with Dr. Mothaffar Rimawi
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
How should we approach first-line treatment as the HER2-positive metastatic breast cancer landscape rapidly evolves?
At This Moment in Medicine, hosted by Community Health Media, Dr. Mothaffar Rimawi examines how new data are reshaping a treatment landscape long defined by the CLEOPATRA regimen.
From DESTINY-Breast09 to PATINA and HER2CLIMB-05, Dr. Rimawi explores emerging strategies for deeper HER2 and ER pathway inhibition, the role of T-DXd, and how clinicians might individualize treatment based on disease biology, burden, toxicity, and patient preference.
Topics discussed:
- The evolution of first-line HER2-positive metastatic breast cancer treatment
- CLEOPATRA and the foundation of modern HER2-directed therapy
- PATINA and the addition of palbociclib in HR+/HER2+ disease
- DESTINY-Breast09 and T-DXd plus pertuzumab
- Depth and duration of response with T-DXd
- HER2CLIMB-05 and tucatinib maintenance
- ILD, transaminitis, and other treatment-related toxicities
- Patient-reported outcomes and quality of life
- Selecting treatment based on ER status, CNS disease, disease burden, and molecular profile
- T-DXd duration and the possibility of induction-maintenance strategies
- How PATINA and HER2CLIMB-05 could inform maintenance therapy
The presentation concludes with a panel discussion addressing a critical question for the field: With several highly effective strategies now available, how do we choose the right first-line approach for the right patient?
▶️ Watch more from This Moment in Medicine and subscribe to Community Health Media for expert conversations on the latest advances shaping cancer care.
🎧 Subscribe for the latest insights from leading cancer specialists.
#ThisMomentInMedicine #MothaffarRimawi #HER2Positive #MetastaticBreastCancer #DESTINYBreast09 #TDXd #PATINA #HER2CLIMB05 #BreastOncology #MedicalOncology #CommunityHealthMedia
–
Thanks for watching!
Our podcasts are also available on:
• Spotify - https://spotf.fi/chm-podcast
• Amazon Music - https://amazn.so/chm-podcast
• Apple Podcast - https://podcasts.apple.com/us/podcast/community-health-media/id1837428248
• Castbox - https://castbox.fm/vh/6735434
• Goodpods - https://goodpods.com/profile/chm-111066
• iHeartRadio - https://iheart.com/podcast/291542082
• Pocket Casts - https://pca.st/3ncdh11o
–
Community Health Media (CHM) is your full service healthcare communications partner, combining our production expertise with targeted multi-channel campaigns. We connect companies and healthcare brands with key opinion leaders, patients, and consumers through compelling content and live experiences.
We’re an integrated marketing company that produces world-class content and curated peer to peer live experiences.
We specialize in:
• Peer to peer interviews, panels & round-tables
• Curated live events & conferences
• Professional in-depth content & research updates
• Interactive learning modules & webinars
• Live & on-demand webcasts & podcasts
Learn more about us here - https://communityhealth.media